Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 627 | 606 | 849 | 422 | 1,190 |
| Cost of Goods | 164 | 109 | 26 | 3 | 535 |
| Gross Profit | 463 | 496 | 823 | 420 | 654 |
| Operating Expenses | 1,285 | 1,997 | 1,469 | 700 | 4,060 |
| Operating Income | -658 | -1,392 | -620 | -278 | -2,870 |
| Interest Expense | 117 | 258 | 19 | 1 | 58 |
| Other Income | 32 | 346 | 1 | 0 | 156 |
| Pre-tax Income | -743 | -1,303 | -638 | -279 | -2,772 |
| Income Tax | N/A | N/A | -330 | 1,595 | N/A |
| Net Income Continuous | -743 | -1,303 | -308 | -1,874 | -2,772 |
| Net Income Discontinuous | N/A | N/A | 524 | -2,537 | N/A |
| Net Income | $-743 | $-1,303 | $216 | $-4,410 | $-2,772 |
| EPS Basic Total Ops | -0.84 | -2.10 | 0.28 | -5.04 | -3.92 |
| EPS Basic Continuous Ops | -0.84 | -1.47 | -0.28 | -2.10 | -3.91 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.56 | -2.94 | N/A |
| EPS Diluted Total Ops | -0.84 | -2.10 | 0.28 | -5.04 | -3.92 |
| EPS Diluted Continuous Ops | -0.84 | -1.47 | -0.28 | -2.10 | -3.91 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.56 | -2.94 | N/A |
| EBITDA(a) | $-492 | $-1,140 | $-451 | $-267 | $-2,604 |